Phase 1b Study of Venetoclax and Alvocidib in Patients with Relapsed/Refractory Acute Myeloid Leukemia
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
AbbVie Inc.
Start Date
October 25, 2018
End Date
October 31, 2023
Administered By
Duke Cancer Institute
Awarded By
AbbVie Inc.
Start Date
October 25, 2018
End Date
October 31, 2023